05:06 AM EDT, 08/10/2026 (MT Newswires) -- Q-linea (QLINEA.ST) received a contract from a major US health system for its ASTar rapid antimicrobial susceptibility testing system. The infection diagnostics company said Monday that it will install the system to serve a network of more than 1,500 hospital beds.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.